These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 29874660
21. Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Howe D, Fraser M, Newnham J. Endocr Res; 2000 Nov; 26(4):489-504. PubMed ID: 11196419 [Abstract] [Full Text] [Related]
22. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Meaney MJ, Szyf M, Seckl JR. Trends Mol Med; 2007 Jul; 13(7):269-77. PubMed ID: 17544850 [Abstract] [Full Text] [Related]
23. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations. Waffarn F, Davis EP. Am J Obstet Gynecol; 2012 Dec; 207(6):446-54. PubMed ID: 22840973 [Abstract] [Full Text] [Related]
24. Antenatal glucocorticoids reset the level of baseline and hypoxemia-induced pituitary-adrenal activity in the sheep fetus during late gestation. Fletcher AJ, Ma XH, Wu WX, Nathanielsz PW, McGarrigle HH, Fowden AL, Giussani DA. Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E311-9. PubMed ID: 14559720 [Abstract] [Full Text] [Related]
25. Prenatal bisphenol a exposure and dysregulation of infant hypothalamic-pituitary-adrenal axis function: findings from the APrON cohort study. Giesbrecht GF, Ejaredar M, Liu J, Thomas J, Letourneau N, Campbell T, Martin JW, Dewey D, APrON Study Team. Environ Health; 2017 May 19; 16(1):47. PubMed ID: 28526030 [Abstract] [Full Text] [Related]
26. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Clark PM. Eur J Pediatr; 1998 Jan 19; 157 Suppl 1():S7-10. PubMed ID: 9462899 [Abstract] [Full Text] [Related]
27. Sex-specific and lasting effects of a single course of antenatal betamethasone treatment on human placental 11β-HSD2. Braun F, Hardt AK, Ehrlich L, Sloboda DM, Challis JRG, Plagemann A, Henrich W, Braun T. Placenta; 2018 Sep 19; 69():9-19. PubMed ID: 30213491 [Abstract] [Full Text] [Related]
28. Prenatal synthetic glucocorticoid exposure alters hypothalamic-pituitary-adrenal regulation and pregnancy outcomes in mature female guinea pigs. Dunn E, Kapoor A, Leen J, Matthews SG. J Physiol; 2010 Mar 01; 588(Pt 5):887-99. PubMed ID: 20064858 [Abstract] [Full Text] [Related]
29. Changes in endocrine and neurochemical profiles in neonatal pigs prenatally exposed to increased maternal cortisol. Kanitz E, Otten W, Tuchscherer M. J Endocrinol; 2006 Oct 01; 191(1):207-20. PubMed ID: 17065404 [Abstract] [Full Text] [Related]
30. Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function. Iqbal M, Moisiadis VG, Kostaki A, Matthews SG. Endocrinology; 2012 Jul 01; 153(7):3295-307. PubMed ID: 22564976 [Abstract] [Full Text] [Related]
31. Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the World Health Organization dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy. Usuda H, Fee EL, Carter S, Furfaro L, Takahashi T, Takahashi Y, Newnham JP, Milad MA, Saito M, Jobe AH, Kemp MW. Am J Obstet Gynecol; 2022 Dec 01; 227(6):903.e1-903.e16. PubMed ID: 35792176 [Abstract] [Full Text] [Related]
32. Prenatal treatment with glucocorticoids sensitizes the hpa axis response to stress among full-term infants. Davis EP, Waffarn F, Sandman CA. Dev Psychobiol; 2011 Mar 01; 53(2):175-83. PubMed ID: 21298632 [Abstract] [Full Text] [Related]
33. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: a systematic review. Carpenter T, Grecian SM, Reynolds RM. J Dev Orig Health Dis; 2017 Apr 01; 8(2):244-255. PubMed ID: 28103963 [Abstract] [Full Text] [Related]
34. Use of Glucocorticoids for the Fetus and Preterm Infant. Scott SM, Rose SR. Clin Perinatol; 2018 Mar 01; 45(1):93-102. PubMed ID: 29406009 [Abstract] [Full Text] [Related]
36. Antenatal dexamethasone: effect on ovine placental 11beta-hydroxysteroid dehydrogenase type 2 expression and fetal growth. Kerzner LS, Stonestreet BS, Wu KY, Sadowska G, Malee MP. Pediatr Res; 2002 Nov 01; 52(5):706-12. PubMed ID: 12409517 [Abstract] [Full Text] [Related]
37. Development of the hypothalamic-pituitary-adrenal axis in the fetus and preterm infant. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. J Pediatr Endocrinol Metab; 2002 Jun 01; 15(6):759-69. PubMed ID: 12099385 [Abstract] [Full Text] [Related]
38. Maternal undernutrition and fetal developmental programming of obesity: the glucocorticoid connection. Correia-Branco A, Keating E, Martel F. Reprod Sci; 2015 Feb 01; 22(2):138-45. PubMed ID: 25001018 [Abstract] [Full Text] [Related]